The 3rd Annual HMNCC GI Oncology Summit - Exhibit Registration
EXHIBITOR/SPONSOR REGISTRATION
You are NOT confirmed to exhibit until you register.
Registration deadline: November 20, 2026
EXHIBIT DETAILS
Date and Time
Friday, December 4, 2026 | 8:00am – 3:45pm
Exhibit Location
Houston Methodist Research Institute
6670 Bertner Ave.
2nd Floor Pre-Function Space
Houston, TX 77030
EXHIBIT FEE TIER 1: $1,000
- One 6’ x 3’ table-top exhibit with two chairs on the tiled floor outside of the pre-function space
- Exhibiting companies may send a maximum of two (2) representatives to staff their exhibit table.
- Recognition in the webpage and activity materials
EXHIBIT FEE TIER 2: $1,350
- One 6’ x 3’ table-top exhibit with two chairs on the carpeted floor directly outside of the auditorium
- Exhibiting companies may send a maximum of two (2) representatives to staff their exhibit table.
- Recognition in the webpage and activity materials
SPONSORSHIP FEE OPTIONS
- BREAK SPONSOR: $1,800 - Recognition in activity materials and signage during break as Sponsor.
- BREAKFAST SPONSOR: $2,700- Recognition in activity materials and signage during breakfast as Sponsor.
- LUNCH SPONSOR: $4,500- Recognition in activity materials and signage during lunch as Sponsor.
- PRODUCT THEATER SPONSOR (3 available): $5,200- Product theater is a 30-minute time slot prior to the start of the symposium or during lunch for a company provided expert to feature your products and services! Product theater located adjacent to educational space.
NOTE: Companies may purchase one exhibit and one sponsorship type.
Course summary
TIME | PRESENTATION | SPEAKERS |
8:00 AM –8:25 AM |
Light Breakfast and Registration | |
8:25 AM – 8:30 AM |
Welcome and Introduction | Jenny C. Chang, MD Director, Dr. Mary and Ron Neal Cancer Center
Maen Abdelrahim, MD, PhD, Pharm B Section Chief of Gastrointestinal Medical Oncology, Dr. Mary and Ron Neal Cancer Center |
8:30 AM –8:35 AM | Session 1: Hepatobiliary Cancer | Maen Abdelrahim, MD, PhD, Pharm B, MD, Karim J. Halazun, MD and Milind Javle, MD, and Aiwu Ruth He, MD, Mazen Noureddin, MD, MHSc |
8:35 AM –8:45 AM | Worldwide Epidemiology and United States Burden of Liver Cancers: Risk Factors and Prevention | Hashem B. El-Serag, MD, MPH |
8:45 AM –8:55 AM | Pathogenesis and Surveillance Modalities of Hepatobiliary Cancer | Amit Singal, MD, MS |
8:55 AM –9:05 AM | Current Status of Pre-Liver Cancer Diseases: Management and Future Directions | Mazen Noureddin, MD, MHSc |
9:05 AM –9:10 AM |
Break | |
9:10 AM – 9:20 AM | Transplant-Bridging Approaches in Hepatocellular Carcinoma | Maen Abdelrahim, MD, PhD, Pharm B |
9:20 AM – 9:30 AM | Updates on Operative Approaches in Early-Stage Hepatobiliary Cancer |
Karim J. Halazun, MD |
9:30 AM – 9:40 AM | New Frontiers for Immunotherapy in Patients with Advanced and Resectable Hepatocellular Carcinoma | Ahmed Kaseb, MD |
9:40 AM – 9:50 AM | Current and Emerging Management in Advanced Cholangiocarcinoma | Milind Javle, MD |
9:50 AM –10:15 AM | Panel Discussion | Maen Abdelrahim, MD, PhD, Pharm B (moderator) Aiwu Ruth He, MD, Mazen Noureddin, MD, MHSc, and Ahmed Kaseb, MD, Karim J. Halazun, MD, Hashem B. El-Serag, MD, MPH, Milind Javle, MD |
10:15 AM –10:20 AM | Session 2: Pancreatic & Neuroendocrine Cancer | Anwaar Saeed, MD, Nestor F. Esnaola, MD, MPH, MBA, FACS, and Philip A Philip, MD |
10:20 AM – 10:30 AM | Updates on Molecular Diagnostics | Mary R. Schwartz, MD |
10:30 AM – 10:40 AM | Updates on Operative and Perioperative Approaches in Pancreatic Adenocarcinoma | Nestor F. Esnaola, MD, MPH, MBA, FACS |
10:40 AM – 10:50 AM | Targeted Therapy Developments in Advanced-Stage Pancreatic Adenocarcinoma | Mohammed Alghamdi, MD, MBA |
10:50 AM – 11:00 AM | Updates in the Management of Low-/Intermediate-Grade Neuroendocrine Carcinoma | Philip A Philip, MD |
11:00 AM – 11:15 AM
|
Panel Discussion | Anwaar Saeed, MD, Nestor F. Esnaola, MD, MPH, MBA, FACS, and Philip A Philip, MD, Mary R. Schwartz, MD |
11:15 AM – 11:55 AM | Keynote: Integrating Immunotherapy into the Neoadjuvant Space in Gastrointestinal Malignancies: A Shifting Paradigm | James P. Allison, Ph. D |
11:55 AM – 12:00 PM |
Session 3: Colorectal Cancer | Eric Haas, MD, and Monisha Singh, MD, Maen Abdelrahim, MD, PhD, Pharm B |
12:00 AM – 12:10 PM | Updates in the Management of Colorectal Liver Metastases | Kirk Heyne, MD |
12:10 AM – 12:20 PM | Advancement in Surgical Management in Colorectal Cancer | Eric Haas, MD |
12:20 AM – 12:30 PM | Immunotherapy Developments in Colorectal Cancer, MSI-H | Anaum Maqsood, MD |
12:30 AM –12:40 PM | Immunotherapy Developments in Colorectal Cancer, MSS | Ali Alqahtani, MD |
12:40 PM – 12:50 PM | Precision Medicine Developments in Colorectal Cancer | Aiwu Ruth He, MD, PhD |
12:50 PM – 01:10 PM
|
Panel Discussion
| Joshua C. Coursey, MD (moderator) Anaum Maqsood, MD, Eric Haas, MD, and Kirk Heyne, MD |
01:00 PM – 02:00 PM | Networking Reception/Lunch | |
02:00 PM – 02:05 PM |
Session4: Esophageal and Gastric Cancer | Aiwu Ruth He, MD, PhD, Fadi I. Abu-Shahin, MD, and Anaum Maqsood, MD |
02:05 PM – 02:15 PM | Advances in Multidisciplinary Approaches in Resectable Gastric/Esophageal Cancer | Anwaar Saeed, MD
|
02:15 PM – 02:25 PM | Immunotherapy Advancements and Predictive Markers in Unresectable Gastroesophageal Adenocarcinoma | Fahad Ibnshamsah, MD |
02:25 PM – 02:35 PM | Precision Medicine Advancements in Unresectable Gastroesophageal Adenocarcinoma | Monisha Singh, MD
|
02:35 PM – 02:55 PM |
Panel Discussion | Monisha Singh, MD, (moderator)Fadi I. Abu-Shahin, MD, Fahad Ibnshamsah, MD and Anwaar Saeed, MD
|
02:55 PM – 03:00 PM | Concluding Remarks | Cochair |

Registration Instructions
- STEP 1 - Select the applicable fee and add to cart to complete the checkout process.
- STEP 2 - Once registered, on the week of the conference you will receive an email from Annie ([email protected]) for more details on exhibiting.

Facebook
X
LinkedIn
Forward